Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03691181 · ClinicalTrials.gov registry record · NA

Home COPD and Open Ventilation Evaluation (HOPE) Study

A NA study of Pulmonary Disease, Chronic Obstructive, sponsored by Landon Pediatric Foundation.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT03691181 is a NA study of Pulmonary Disease, Chronic Obstructive that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 6 participants, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03691181, a NA study of Pulmonary Disease, Chronic Obstructive, has completed, sponsored by Landon Pediatric Foundation.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Respiratory related diseases such as chronic obstructive pulmonary disease (COPD) and neuromuscular diseases remain a major public health issue affecting millions of people worldwide. More than 15 million people are estimated to be diagnosed with COPD in the US alone. In the US, the direct and indirect costs associated with COPD are estimated to be about $50 billion. Clinical studies have shown that by providing ventilation to reduce respiratory insufficiency symptoms such as dyspnea, patients may become more tolerant to exercise and be able to increase their participation in activities of daily living resulting in an overall positive impact in their quality of lives. The Life2000 Ventilation System, with the smallest tubing and comfortable interface solutions, is the only ventilator to simultaneously provide full ventilatory support and enable patients to ambulate. The Life2000 Ventilation System is an FDA-cleared critical care ventilator (K141943/S003, June 2015) indicated for use for adult patients who require positive pressure ventilation delivered invasively or non-invasively. The device, classified by FDA as a continuous ventilator, can treat both acute and chronic respiratory failure and is suitable for use in home and institutional settings by qualified, trained personnel under the direction of a physician. The Life2000 Compressor is intended to provide a 50-psi pressure source to the ventilator and is currently in the FDA premarket notification (510 k) clearance process, so its use is considered investigational.

Interventions

  • DEVICE Ventilation

Study Locations (1)

California

  • VCMC - Ventura

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2017-01
Est. Completion 2018-06
Phase NA

Sponsor

Landon Pediatric Foundation

11 total trials

What the Registry Record Tells You About NCT03691181

The ClinicalTrials.gov registry entry for NCT03691181 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (99% lower). The listed sponsor is Landon Pediatric Foundation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Ventilation is the first listed.

NCT03691181 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03691181 about?

NCT03691181 is a clinical study titled "Home COPD and Open Ventilation Evaluation (HOPE) Study". Respiratory related diseases such as chronic obstructive pulmonary disease (COPD) and neuromuscular diseases remain a major public health issue affecting millions of people worldwide. More than 15 million people are estimated to be diagnosed with COPD in the US alone. In the US, the direct and indir...

What is the current status of trial NCT03691181?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-01. Estimated completion is 2018-06.

What conditions does trial NCT03691181 study?

This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive.

What interventions are being tested in trial NCT03691181?

The interventions under investigation include: Ventilation (DEVICE).

Who is sponsoring clinical trial NCT03691181?

This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03691181 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Disease, Chronic Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.